Canada Pauses AstraZeneca Vaccine

The advisory committee recommended halting the AstraZeneca vaccine for people 55 and younger due to concerns about rare blood clots. Similar cases were reported in Europe, but the European Medicines Agency found no evidence linking the vaccine to blood clots. The committee does not expect this stoppage to significantly delay vaccinations in Canada.

What age group was mentioned in relation to the advisory committee's concerns?

• 55 years old and younger

• 60 years old and younger

• 50 years old and younger

• All ages

What was the reason for the advisory committee's recommendation to stop?

• Concerns about blood clots

• Lack of vaccine supply

• Public protests

• Ineffective vaccine

What recent event in Europe was mentioned in relation to the vaccine?

• Similar cases of blood clots

• Increased vaccination rates

• Vaccine shortages

• Public protests against vaccination

What did the European Medicines Agency say about the Astra Zeneca vaccine?

• It causes blood clots

• There is no evidence it causes blood clots

• It is ineffective

• It is only for older adults

What impact does the committee expect the stoppage to have on vaccinations in Canada?

• Significant delay

• No significant delay

• Complete halt

• Increased vaccination rates